|Other Names||Protocadherin-9, PCDH9|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13185b was selected from the C-term region of PCDH9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Function||Potential calcium-dependent cell-adhesion protein.|
|Cellular Location||Cell membrane; Single-pass type I membrane protein|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene belongs to the protocadherin gene family, asubfamily of the cadherin superfamily. The mRNA encodes acadherin-related neuronal receptor that localizes to synapticjunctions and is putatively involved in specific neuronalconnections and signal transduction. Sharing a characteristic withother protocadherin genes, this gene has a notably large exon thatencodes six cadherin domains and a transmembrane region. Twoalternatively spliced transcript variants encoding distinctisoforms have been found for this gene.
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Talmud, P.J., et al. Am. J. Hum. Genet. 85(5):628-642(2009)Nollet, F., et al. J. Mol. Biol. 299(3):551-572(2000)Yagi, T., et al. Genes Dev. 14(10):1169-1180(2000)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.